Abiopharma

New Form 144 - SERA PROGNOSTICS, INC. Filed: 2025-08-11 AccNo: 0001979974-25-000004 Size: 6 KB

Nuvectis Pharma Announces the Initiation of the Phase 1b Program for NXP900

New Form 8-K - HARVARD BIOSCIENCE INC Filed: 2025-08-11 AccNo: 0001171843-25-005288 Size: 288 KB Item 1.01: Entry into a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

New Form 8-K - Aditxt, Inc. Filed: 2025-08-11 AccNo: 0001213900-25-074330 Size: 323 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

New Form 8-K - MAXCYTE, INC. Filed: 2025-08-11 AccNo: 0001558370-25-011056 Size: 152 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

New Form 4 - Addus HomeCare Corp Filed: 2025-08-11 AccNo: 0001437749-25-025944 Size: 4 KB

Serina Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Highlights

New Form 424B3 - Oruka Therapeutics, Inc. Filed: 2025-08-11 AccNo: 0001213900-25-074322 Size: 939 KB

New Form SCHEDULE 13G/A - Cabaletta Bio, Inc. Filed: 2025-08-11 AccNo: 0001470831-25-000124 Size: 6 KB

New Form 144 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-08-11 AccNo: 0001950047-25-005633 Size: 9 KB

New Form 4 - KORU Medical Systems, Inc. Filed: 2025-08-11 AccNo: 0001161697-25-000250 Size: 11 KB

New Form 4 - HENRY SCHEIN INC Filed: 2025-08-11 AccNo: 0000950170-25-106588 Size: 5 KB

New Form 144 - MADRIGAL PHARMACEUTICALS, INC. Filed: 2025-08-11 AccNo: 0001950047-25-005631 Size: 9 KB

New Form 10-Q - PALISADE BIO, INC. Filed: 2025-08-11 AccNo: 0000950170-25-106587 Size: 7 MB

New Form 8-K - U S PHYSICAL THERAPY INC /NV Filed: 2025-08-11 AccNo: 0000885978-25-000044 Size: 406 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits